SCHEMBL21667318

SCHEMBL21667318

CC(C)n1c(=O)cc(NCc2ccccc2C#N)[nH]c1=O

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.50
▸ CYP2B6 P20813 1/20 0.50
▸ GRIN1 Q05586 7/20 0.39
▸ GRIN2B Q13224 7/20 0.39
▸ DPP4 P27487 1/20 0.39
▸ PGR P06401 1/20 0.38
▸ P2RX7 Q99572 2/20 0.38
▸ TP53 P04637 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ IDH1 O75874 1/20 0.36
▸ CHRM1 P11229 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21667279 0.83 CYP3A4 (0.54) CYP3A4CYP2B6TP53SMN1; SMN2ALDH1A1
SCHEMBL21667323 0.83 CYP3A4 (0.54) CYP3A4CYP2B6P2RX7TP53SMN1; SMN2
SCHEMBL21667350 0.82 CYP3A4 (0.53) CYP3A4CYP2B6TP53SMN1; SMN2IDH1
SCHEMBL21667337 0.82 CYP3A4 (0.53) CYP3A4CYP2B6PGRTP53SMN1; SMN2
SCHEMBL21667335 0.80 CYP3A4 (0.51) CYP3A4CYP2B6P2RX7ALDH1A1L3MBTL1
SCHEMBL21667363 0.79 CYP3A4 (0.50) CYP3A4CYP2B6P2RX7
SCHEMBL20716038 0.79 CYP3A4 (0.61) CYP3A4CYP2B6TP53SMN1; SMN2ALDH1A1
SCHEMBL16321489 0.78 CYP3A4 (0.64) CYP3A4CYP2B6PGRSMN1; SMN2IDH1
SCHEMBL16321488 0.78 CYP3A4 (0.64) CYP3A4CYP2B6PGRSMN1; SMN2IDH1
SCHEMBL24469599 0.76 CYP3A4 (0.45) CYP3A4CYP2B6PGRP2RX7TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3702352-A1 PYRIMIDINEDIONE COMPOUND AGAINST CARDIAC CONDITIONS Myokardia, Inc. (US) 2020-09-02 — — EP disclosed
EP-3010910-B1 PYRIMIDINEDIONE COMPOUNDS AGAINST CARDIAC CONDITIONS MYOKARDIA INC (US) 2020-02-05 — — EP disclosed
Send feedback